Cellular Horizons: Improving decisions about access to stem cell interventions

Cellular Horizons: Improving decisions about access to stem cell interventions

This research collaboration explores how best to support decision making around patients' access to cellular therapies.

Stem cell and other cellular therapies offer enormous hope to patients with a wide range of conditions including arthritis, cerebral palsy, Parkinson’s disease, motor neuron disease and multiple sclerosis.

Over the next three years, ethicists, lawyers and social scientists from four universities (University of Sydney, Monash University, University of Melbourne and National University of Singapore) will work with consumers, clinicians and policymakers to devise ways of supporting people making decisions about access to cellular therapies. Researchers from Monash University, The University of Melbourne and Murdoch Children’s Research Institute will conduct Stage 1 of the research which involves interviews with patients, carers, clinicians and other key stakeholders.

This research will generate principles and guidelines to inform when access to cellular therapies should be through clinical trials and when and how they should be offered in clinical practice. It will also develop principles for shared decision-making, education and communication strategies to help patients understand their options and make decisions that are truly reflective of their values, needs and healthcare goals.

Participating universities

logos clockwise from left: Monash University, Macquarie University, University of Melbourne, National University of Singapore, University of Sydney